PartsTable
Technical Data Sheet
NDC00087-0580-19 ✓ Verified by PartsTable
· COMPONENT
WHAT YOU NEED TO KNOW
Verify manufacturer and server generation compatibility Check if Option PN or Spare PN — same part, different channel
Confirm exact part number — similar PNs may be different parts
PRODUCT OVERVIEW

CHOLESTYRAMINE FOR ORAL SUSPENSI. Key specifications include physical_form: POWDER, primary_container_type: CAN, medical_designation_and_grade: UNITED STATES PHARMACOPEIA, primary_container_content_quantity: 378.000 GRAMS G, active_medicament_medicinal_strength: 4.000 GRAMS CHOLESTYRAMINE RESIN, ANHYDROUS EQUIVALENT G, part_name_assigned_by_controlling_agency: CHOLESTYRAMINE FOR ORAL SUSPENSION USP 4GM EQUIV/DOSE 378GM. This product is currently in active production with full OEM support.

This part is cataloged in the Federal Logistics Information System (FLIS) under NSN 6505-01-274-2720, indicating validated use in U.S. government and defense logistics supply chains. Available through authorized enterprise resellers and TPM (Third Party Maintenance) channels.

Verify compatibility with your specific system configuration before ordering.

WHERE IT FITS
NDC00087-0580-19
NSN: 6505-01-274-2720
FSC: 6505
CAGE: 29398 — MEAD JOHNSON & COMPANY, LLC (USA)
SPECIFICATIONS
physical_formPOWDER
primary_container_typeCAN
medical_designation_and_gradeUNITED STATES PHARMACOPEIA
primary_container_content_quantity378.000 GRAMS G
active_medicament_medicinal_strength4.000 GRAMS CHOLESTYRAMINE RESIN, ANHYDROUS EQUIVALENT G
part_name_assigned_by_controlling_agencyCHOLESTYRAMINE FOR ORAL SUSPENSION USP 4GM EQUIV/DOSE 378GM
NSN6505-01-274-2720
COMPONENT DIAGRAM
COMPONENT MAIN IC EDGE CONNECTOR No detailed specs available CHOLESTYRAMINE FOR ORAL SUSPENSI TITLE COMPONENT PN NDC00087-0580-19 MFR CHOLESTYRAMINE FOR ORA
KEY FEATURES
PHYSICAL FORM: POWDER
PRIMARY CONTAINER CONTENT QUANTITY: 378.000 GRAMS G
PRIMARY CONTAINER TYPE: CAN
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 4.000 GRAMS CHOLESTYRAMINE RESIN, ANHYDROUS EQUIVALENT G
MEDICAL DESIGNATION AND GRADE: UNITED STATES PHARMACOPEIA
TECHNICAL CHARACTERISTICS (FLIS)
PHYSICAL FORMPOWDER
SPECIAL FEATURES42 DOSES PER CAN; CAN TO CONTAIN A SCOOP TO MEASURE 9 GRAMS; EACH 9 GRAM (DOSE) SCOOP CONTAINS 4 GRAMS ANHYDROUS CHOLESTYRAMINE RESIN EQUIVALENT; IN SUITABLE EXCIPIENTS FLAVORING AND COLORING AGENTS G
PART NAME ASSIGNED BY CONTROLLING AGENCYCHOLESTYRAMINE FOR ORAL SUSPENSION USP 4GM EQUIV/DOSE 378GM
PRIMARY CONTAINER CONTENT QUANTITY378.000 GRAMS G
PRIMARY CONTAINER TYPECAN
ACTIVE MEDICAMENT MEDICINAL STRENGTH4.000 GRAMS CHOLESTYRAMINE RESIN, ANHYDROUS EQUIVALENT G
MEDICAL DESIGNATION AND GRADEUNITED STATES PHARMACOPEIA
VERIFIED SUBSTITUTES & CROSS-REFERENCES 12
70009Interchangeable
interchangeable cross-reference
interchangeable
30-955-1PC23Interchangeable
interchangeable cross-reference
interchangeable
GGG-K-275Interchangeable
interchangeable cross-reference
interchangeable
SE5430-131Interchangeable
interchangeable cross-reference
interchangeable
5430-175Interchangeable
interchangeable cross-reference
interchangeable
58012Interchangeable
interchangeable cross-reference
interchangeable
LIFECYCLE
StatusACTIVE
AvailabilityOEM and secondary market
RoHS CompliantEAR99Not HAZMAT
Ready to buy NDC00087-0580-19?
Compare prices from verified sellers on eBay
Buy on eBay →
As an eBay Partner, PartsTable may earn a commission. Your price is not affected.
FREQUENTLY ASKED QUESTIONS
What is NDC00087-0580-19?
NDC00087-0580-19 is a CHOLESTYRAMINE FOR ORAL SUSPENSI.
What parts can replace NDC00087-0580-19?
There are 12 known substitutes for NDC00087-0580-19: 70009, 30-955-1PC23, GGG-K-275 and 9 more. Substitute compatibility should be verified for your specific system.
What is the NSN for NDC00087-0580-19?
NDC00087-0580-19 is cataloged in the Federal Logistics Information System (FLIS) under NSN 6505-01-274-2720. This indicates validated use in U.S. government and defense supply chains.
Community Feedback
Comments (0)
No comments yet. Be the first to share what you know.
Leave a Comment
Comments are reviewed before appearing. You will receive an email to verify before your comment appears.

Request a Quote — NDC00087-0580-19